Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,140.40
(
0.52%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.64
(
2.38%
)
Bitcoin
74,755.92
(
-0.12%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jellybean

Send PM Follow Ignore
Followers 10
Posts 1099
Boards Moderated 0
Alias Born 08/23/2004

jellybean

Re: DewDiligence post# 131661

Wednesday, 11/23/2011 12:45:00 PM

Wednesday, November 23, 2011 12:45:00 PM

Post# of 257253
Yes, this changes the patent landscape. AMGN did a fantastic job protecting their Epogen franchise from infringement and I imagine they will do the same for Enbrel. Inventing around the IP will require real science and not a generic makeover.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now